Changchun BCHT Biotechnology Co. A
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company's products include herpes zoster vaccine; varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 200… Read more
Market Cap & Net Worth: Changchun BCHT Biotechnology Co. A (688276)
Changchun BCHT Biotechnology Co. A (SHG:688276) has a market capitalization of $1.06 Billion (CN¥7.78 Billion) as of March 18, 2026. Listed on the SHG stock exchange, this China-based company holds position #12973 globally and #3279 in its home market, demonstrating a 1.18% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Changchun BCHT Biotechnology Co. A's stock price CN¥18.81 by its total outstanding shares 413657598 (413.66 Million).
Changchun BCHT Biotechnology Co. A Market Cap History: 2021 to 2026
Changchun BCHT Biotechnology Co. A's market capitalization history from 2021 to 2026. Data shows change from $3.84 Billion to $1.06 Billion (-32.18% CAGR).
Changchun BCHT Biotechnology Co. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Changchun BCHT Biotechnology Co. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.15x
Changchun BCHT Biotechnology Co. A's market cap is 1.15 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
6.10x
Changchun BCHT Biotechnology Co. A's market cap is 6.10 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $3.84 Billion | $1.20 Billion | $243.55 Million | 3.19x | 15.75x |
| 2022 | $3.87 Billion | $1.07 Billion | $181.54 Million | 3.61x | 21.32x |
| 2023 | $3.08 Billion | $1.81 Billion | $501.01 Million | 1.70x | 6.14x |
| 2024 | $1.42 Billion | $1.23 Billion | $232.09 Million | 1.15x | 6.10x |
Competitor Companies of 688276 by Market Capitalization
Companies near Changchun BCHT Biotechnology Co. A in the global market cap rankings as of March 18, 2026.
Key companies related to Changchun BCHT Biotechnology Co. A by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Changchun BCHT Biotechnology Co. A Historical Marketcap From 2021 to 2026
Between 2021 and today, Changchun BCHT Biotechnology Co. A's market cap moved from $3.84 Billion to $ 1.06 Billion, with a yearly change of -32.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.06 Billion | -0.27% |
| 2025 | CN¥1.06 Billion | -24.89% |
| 2024 | CN¥1.42 Billion | -54.00% |
| 2023 | CN¥3.08 Billion | -20.50% |
| 2022 | CN¥3.87 Billion | +0.91% |
| 2021 | CN¥3.84 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Changchun BCHT Biotechnology Co. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.06 Billion USD |
| MoneyControl | $1.06 Billion USD |
| MarketWatch | $1.06 Billion USD |
| marketcap.company | $1.06 Billion USD |
| Reuters | $1.06 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.